Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial

BACKGROUND: Prostatic artery embolisation (PAE) is a minimally invasive treatment of symptomatic benign prostatic hyperplasia (BPH). Our aim was to compare patient's symptoms improvement after PAE and medical treatment. METHODS: A randomised, open-label, superiority trial was set in 10 French h...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapoval, Marc, Thiounn, Nicolas, Descazeaud, Aurélien, Déan, Carole, Ruffion, Alain, Pagnoux, Gaële, Duarte, Ricardo Codas, Robert, Grégoire, Petitpierre, Francois, Karsenty, Gilles, Vidal, Vincent, Murez, Thibaut, Vernhet-Kovacsik, Hélène, de la Taille, Alexandre, Kobeiter, Hicham, Mathieu, Romain, Heautot, Jean-Francois, Droupy, Stéphane, Frandon, Julien, Barry Delongchamps, Nicolas, Korb-Savoldelli, Virginie, Durand-Zaleski, Isabelle, Pereira, Helena, Chatellier, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320610/
https://www.ncbi.nlm.nih.gov/pubmed/37415648
http://dx.doi.org/10.1016/j.lanepe.2023.100672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320610/
https://www.ncbi.nlm.nih.gov/pubmed/37415648
http://dx.doi.org/10.1016/j.lanepe.2023.100672

Ejemplares similares